E-LIB Suche - Ergebnisse für: Ivy, S. Percy

1

Impact of the 2021 CKD-EPI equation on anticancer pharmacot..:

Butrovich, Morgan A. ; Qin, Jiyue ; Xue, Xiaonan...
Cancer Letters. 586 (2024) - p. 216679 , 2024

Link: https://doi.org/10.1016/..

2

A phase 2 trial exploring the significance of homologous re..:

Liu, Joyce F. ; Xiong, Niya ; Wenham, Robert M....
Gynecologic Oncology. 187 (2024) - p. 105-112 , 2024

Link: https://doi.org/10.1016/..

3

The New NCI Precision Medicine Trials:

Harris, Lyndsay N. ; Blanke, Charles D. ; Erba, Harry P....
Clinical Cancer Research. 29 (2023) 23 - p. 4728-4732 , 2023

Link: https://doi.org/10.1158/..

4

A phase 1 study of veliparib (ABT-888) plus weekly carbopla..:

Malhotra, Monica K. ; Pahuja, Shalu ; Kiesel, Brian F....
Breast Cancer Research and Treatment. 198 (2023) 3 - p. 487-498 , 2023

Link: https://doi.org/10.1007/..

5

Multicenter Phase II Trial of the PARP Inhibitor Olaparib i..:

Fanucci, Kristina ; Pilat, Mary Jo ; Shyr, Derek...
Cancer Research Communications. 3 (2023) 2 - p. 192-201 , 2023

Link: https://doi.org/10.1158/..

6

Enhancing reporting quality and impact of early phase dose-..:

Yap, Christina ; Solovyeva, Olga ; de Bono, Johann...
BMJ. , 2023

Link: https://doi.org/10.1136/..

7

Survey of Lifestyle, Past Medical History and Complementary..:

Olaku, Oluwadamilola ; Conley, Barbara A. ; Ivy, S. Percy...
Translational Oncology. 25 (2022) - p. 101484 , 2022

Link: https://doi.org/10.1016/..

8

Implementing Modernized Eligibility Criteria in US National..:

Denicoff, Andrea M ; Ivy, S Percy ; Tamashiro, Tami T...
JNCI: Journal of the National Cancer Institute. 114 (2022) 11 - p. 1437-1440 , 2022

Link: https://doi.org/10.1093/..

9

Randomized Phase II Trial of Sunitinib or Cediranib in Alve..:

Nguyen, James ; Takebe, Naoko ; Kummar, Shivaani...
Clinical Cancer Research. 29 (2022) 7 - p. 1200-1208 , 2022

Link: https://doi.org/10.1158/..

10

Early drug development in solid tumours: analysis of Nation..:

Chihara, Dai ; Lin, Ruitao ; Flowers, Christopher R...
The Lancet. 400 (2022) 10351 - p. 512-521 , 2022

Link: https://doi.org/10.1016/..

11

Phase I pharmacokinetic study of single agent trametinib in..:

Voon, Pei Jye ; Chen, Eric X. ; Chen, Helen X....
Journal of Experimental & Clinical Cancer Research. 41 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

12

Outcomes of Pregnancy During Immunotherapy Treatment for Ca..:

Mittra, Arjun ; Naqash, Abdul Rafeh ; Murray, James H....
The Oncologist. 26 (2021) 10 - p. e1883-e1886 , 2021

Link: https://doi.org/10.1002/..

13

Clinical Activity and Safety of Cediranib and Olaparib Comb..:

Kim, Joseph W. ; Cardin, Dana B. ; Vaishampayan, Ulka N....
The Oncologist. 26 (2021) 7 - p. e1104-e1109 , 2021

Link: https://doi.org/10.1002/..

14

Blood-based biomarkers in patients with platinum-sensitive ..:

Nixon, Andrew ; Liu, Joyce ; Xiong, Niya...
Gynecologic Oncology. 162 (2021) - p. S99 , 2021

Link: https://doi.org/10.1016/..

15

Combined PARP and HSP90 inhibition: preclinical and Phase 1..:

Konstantinopoulos, Panagiotis A. ; Cheng, Su-Chun ; Supko, Jeffrey G....
British Journal of Cancer. 126 (2021) 7 - p. 1027-1036 , 2021

Link: https://doi.org/10.1038/..